Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Comparison of Phenotypes and Risk Factors for Esophageal Adenocarcinoma at Present vs Prior Decades.

Sawas T, Azad N, Killcoyne S, Iyer PG, Wang KK, Fitzgerald RC, Katzka DA.

Clin Gastroenterol Hepatol. 2019 Nov 8. pii: S1542-3565(19)31269-8. doi: 10.1016/j.cgh.2019.11.014. [Epub ahead of print]

PMID:
31712077
2.

Targeting the COX1/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma development.

Zhang T, Wang Q, Ma WY, Wang K, Chang X, Johnson ML, Bai R, Bode AM, Foster NR, Falk GW, Limburg PJ, Iyer PG, Dong Z.

EBioMedicine. 2019 Nov 6. pii: S2352-3964(19)30709-1. doi: 10.1016/j.ebiom.2019.10.038. [Epub ahead of print]

3.

Dysplasia detection in Barrett's esophagus: Is the glass half full or half empty?

Iyer PG.

Gastrointest Endosc. 2019 Nov;90(5):742-744. doi: 10.1016/j.gie.2019.06.035. No abstract available.

PMID:
31635713
4.

Reply to a Letter to Editor About the Manuscript: Unsedated Transnasal Endoscopy for Preoperative Examination of Bariatric Patients-a Prospective Study.

Xavier AT, Alvares AV, Iyer PG, Arantes VN.

Obes Surg. 2019 Oct 19. doi: 10.1007/s11695-019-04223-6. [Epub ahead of print] No abstract available.

PMID:
31630325
5.

Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma.

Qin Y, Wu CW, Taylor WR, Sawas T, Burger KN, Mahoney DW, Sun Z, Yab TC, Lidgard GP, Allawi HT, Buttar NS, Smyrk TC, Iyer PG, Katzka DA, Ahlquist DA, Kisiel JB.

Clin Cancer Res. 2019 Sep 16. doi: 10.1158/1078-0432.CCR-19-0740. [Epub ahead of print]

PMID:
31527170
6.

Barrett Esophagus.

Iyer PG, Kaul V.

Mayo Clin Proc. 2019 Sep;94(9):1888-1901. doi: 10.1016/j.mayocp.2019.01.032. Review.

PMID:
31486383
7.

Miniature gastrointestinal endoscopy: Now and the future.

McGoran JJ, McAlindon ME, Iyer PG, Seibel EJ, Haidry R, Lovat LB, Sami SS.

World J Gastroenterol. 2019 Aug 14;25(30):4051-4060. doi: 10.3748/wjg.v25.i30.4051. Review.

8.

Risk of progression in Barrett's esophagus indefinite for dysplasia: a systematic review and meta-analysis.

Krishnamoorthi R, Mohan BP, Jayaraj M, Wang KK, Katzka DA, Ross A, Adler DG, Iyer PG.

Gastrointest Endosc. 2019 Aug 14. pii: S0016-5107(19)32121-2. doi: 10.1016/j.gie.2019.07.037. [Epub ahead of print] Review.

PMID:
31421077
9.

Unsedated Transnasal Endoscopy for Preoperative Examination of Bariatric Patients: a Prospective Study.

Xavier AT, Alvares AV, Iyer PG, Arantes VN.

Obes Surg. 2019 Aug 3. doi: 10.1007/s11695-019-04120-y. [Epub ahead of print]

PMID:
31377993
10.

Novel Screening Tests for Barrett's Esophagus.

Codipilly DC, Iyer PG.

Curr Gastroenterol Rep. 2019 Jul 25;21(9):42. doi: 10.1007/s11894-019-0710-9. Review.

PMID:
31346777
11.

Barrett oesophagus.

Peters Y, Al-Kaabi A, Shaheen NJ, Chak A, Blum A, Souza RF, Di Pietro M, Iyer PG, Pech O, Fitzgerald RC, Siersema PD.

Nat Rev Dis Primers. 2019 May 23;5(1):35. doi: 10.1038/s41572-019-0086-z. Review.

PMID:
31123267
12.

Interpretation of volumetric laser endomicroscopy in Barrett's esophagus using image enhancement software.

Kamboj AK, Hoversten P, Kahn AK, Trindade AJ, Iyer PG, Wang KK, Leggett CL.

Dis Esophagus. 2019 May 9. pii: doz037. doi: 10.1093/dote/doz037. [Epub ahead of print]

PMID:
31069389
13.

Hodgkin lymphoma presenting with orbital involvement.

Weiss SJ, McGuire RS, Iyer PG, Yanoff M.

Can J Ophthalmol. 2019 Apr;54(2):e73-e76. doi: 10.1016/j.jcjo.2018.06.019. Epub 2018 Aug 25. No abstract available.

PMID:
30975367
14.

Safety, Diagnostic Accuracy, and Effects of Endoscopic Ultrasound Fine-Needle Aspiration on Detection of Extravascular Migratory Metastases.

Rustagi T, Gleeson FC, Chari ST, Lehrke HD, Takahashi N, Malikowski TM, Abu Dayyeh BK, Chandrasekhara V, Iyer PG, Kendrick ML, Pearson RK, Petersen BT, Rajan E, Smoot RL, Storm AC, Topazian MD, Truty MJ, Vege SS, Wang KK, Levy MJ.

Clin Gastroenterol Hepatol. 2019 Nov;17(12):2533-2540.e1. doi: 10.1016/j.cgh.2019.03.043. Epub 2019 Apr 3.

PMID:
30953754
15.

Staging of T1 esophageal adenocarcinoma with volumetric laser endomicroscopy: a feasibility study.

Kahn A, Kamboj AK, Muppa P, Sawas T, Lutzke LS, Buras MR, Golafshar MA, Katzka DA, Iyer PG, Smyrk TC, Wang KK, Leggett CL.

Endosc Int Open. 2019 Apr;7(4):E462-E470. doi: 10.1055/a-0838-5326. Epub 2019 Mar 21.

16.

A matched cohort examination of publication rates among clinical subspecialty fellows enrolled in a translational science training program.

Ehlers SL, Cornelius KE, Greenberg-Worisek AJ, Warner DO, Weavers KM, Thomson KR, Hansen MJ, Larson JJ, Enders FT, Iyer PG.

J Clin Transl Sci. 2018 Oct;2(5):327-333. doi: 10.1017/cts.2018.336.

17.

Predictors of Progression in Barrett's Esophagus.

Chakraborty S, Iyer PG.

Curr Treat Options Gastroenterol. 2019 Mar;17(1):18-31. doi: 10.1007/s11938-019-00214-9. Review.

PMID:
30796604
18.

No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.

Dong J, Gharahkhani P, Chow WH, Gammon MD, Liu G, Caldas C, Wu AH, Ye W, Onstad L, Anderson LA, Bernstein L, Pharoah PD, Risch HA, Corley DA, Fitzgerald RC; Stomach and Esophageal Cancer Study Consortium, Iyer PG, Reid BJ, Lagergren J, Shaheen NJ, Vaughan TL, MacGregor S, Love S, Palles C, Tomlinson I, Gockel I, May A, Gerges C, Anders M, Böhmer AC, Becker J, Kreuser N, Thieme R, Noder T, Venerito M, Veits L, Schmidt T, Schmidt C, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Mayershofer R, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM, Moebus S, Knapp M, Peters WHM, Neuhaus H, Rösch T, Ell C, Jankowski J, Schumacher J, Neale RE, Whiteman DC, Thrift AP.

Clin Gastroenterol Hepatol. 2019 Oct;17(11):2227-2235.e1. doi: 10.1016/j.cgh.2019.01.041. Epub 2019 Feb 1.

PMID:
30716477
19.

Response.

Codipilly DC, Qin Y, Dawsey SM, Kisiel J, Topazian M, Ahlquist D, Iyer PG.

Gastrointest Endosc. 2019 Feb;89(2):444. doi: 10.1016/j.gie.2018.10.006. No abstract available.

PMID:
30665539
20.

Timeline and location of recurrence following successful ablation in Barrett's oesophagus: an international multicentre study.

Sami SS, Ravindran A, Kahn A, Snyder D, Santiago J, Ortiz-Fernandez-Sordo J, Tan WK, Dierkhising RA, Crook JE, Heckman MG, Johnson ML, Lansing R, Ragunath K, di Pietro M, Wolfsen H, Ramirez F, Fleischer D, Wang KK, Leggett CL, Katzka DA, Iyer PG.

Gut. 2019 Aug;68(8):1379-1385. doi: 10.1136/gutjnl-2018-317513. Epub 2019 Jan 11.

PMID:
30635408
21.

What Constitutes Optimal Management of T1N0 Esophageal Adenocarcinoma?

Ramay FH, Vareedayah AA, Visrodia K, Iyer PG, Wang KK, Eluri S, Shaheen NJ, Reddy R, Martin LW, Greenwald BD, Edwards MA.

Ann Surg Oncol. 2019 Mar;26(3):714-731. doi: 10.1245/s10434-018-07118-5. Epub 2019 Jan 3. Review.

PMID:
30607765
22.

Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.

Sawas T, Alsawas M, Bazerbachi F, Iyer PG, Wang KK, Murad MH, Katzka DA.

Gastrointest Endosc. 2019 May;89(5):913-925.e6. doi: 10.1016/j.gie.2018.11.035. Epub 2018 Dec 7. Review.

PMID:
30529044
23.

Endosheath ultrathin transnasal endoscopy is a cost-effective method for screening for Barrett's esophagus in patients with GERD symptoms.

Honing J, Kievit W, Bookelaar J, Peters Y, Iyer PG, Siersema PD.

Gastrointest Endosc. 2019 Apr;89(4):712-722.e3. doi: 10.1016/j.gie.2018.10.024. Epub 2018 Oct 29.

PMID:
30385112
24.

Outcome of endoscopic mucosal resection in Barrett's esophagus determined by systematic quantification of epithelial glands using volumetric laser endomicroscopy.

Kamboj AK, Kahn A, Sawas T, Lutzke LS, Iyer PG, Wang KK, Leggett CL.

Gastrointest Endosc. 2019 Apr;89(4):701-708.e1. doi: 10.1016/j.gie.2018.09.038. Epub 2018 Oct 16.

25.

Response to Kosmidou et al.

Iyer PG, Ahlquist DA.

Am J Gastroenterol. 2018 Nov;113(11):1723. doi: 10.1038/s41395-018-0362-7. Epub 2018 Oct 17. No abstract available.

PMID:
30333549
26.

Young Adults With Esophageal Adenocarcinoma Present With More Advanced Stage Tumors and Have Shorter Survival Times.

Sawas T, Manrique GC, Iyer PG, Wang KK, Katzka DA.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1756-1762. doi: 10.1016/j.cgh.2018.09.031. Epub 2018 Sep 27.

PMID:
30267861
27.

The African Esophageal Cancer Consortium: A Call to Action.

Van Loon K, Mwachiro MM, Abnet CC, Akoko L, Assefa M, Burgert SL, Chasimpha S, Dzamalala C, Fleischer DE, Gopal S, Iyer PG, Kaimila B, Kayamba V, Kelly P, Leon ME, Mathew CG, Menya D, Middleton D, Mlombe Y, Mmbaga BT, Mmbaga E, Mulima G, Murphy G, Mushi B, Mwanga A, Mwasamwaja A, Parker MI, Pritchett N, Schüz J, Topazian MD, White RE, McCormack V, Dawsey SM.

J Glob Oncol. 2018 Sep;4:1-9. doi: 10.1200/JGO.17.00163. Review.

28.

Combined Celiac Ganglia and Plexus Neurolysis Shortens Survival, Without Benefit, vs Plexus Neurolysis Alone.

Levy MJ, Gleeson FC, Topazian MD, Fujii-Lau LL, Enders FT, Larson JJ, Mara K, Abu Dayyeh BK, Alberts SR, Hallemeier CL, Iyer PG, Kendrick ML, Mauck WD, Pearson RK, Petersen BT, Rajan E, Takahashi N, Vege SS, Wang KK, Chari ST.

Clin Gastroenterol Hepatol. 2019 Mar;17(4):728-738.e9. doi: 10.1016/j.cgh.2018.08.040. Epub 2018 Sep 12.

PMID:
30217513
29.

Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts.

Sawas T, Killcoyne S, Iyer PG, Wang KK, Smyrk TC, Kisiel JB, Qin Y, Ahlquist DA, Rustgi AK, Costa RJ, Gerstung M, Fitzgerald RC, Katzka DA; OCCAMS Consortium.

Gastroenterology. 2018 Dec;155(6):1720-1728.e4. doi: 10.1053/j.gastro.2018.08.036. Epub 2018 Aug 27.

30.

Acceptability, Accuracy, and Safety of Disposable Transnasal Capsule Endoscopy for Barrett's Esophagus Screening.

Sami SS, Iyer PG, Pophali P, Halland M, di Pietro M, Ortiz-Fernandez-Sordo J, White JR, Johnson M, Guha IN, Fitzgerald RC, Ragunath K.

Clin Gastroenterol Hepatol. 2019 Mar;17(4):638-646.e1. doi: 10.1016/j.cgh.2018.07.019. Epub 2018 Aug 3.

31.

Obesity and GERD impair esophageal epithelial permeability through 2 distinct mechanisms.

Blevins CH, Dierkhising RA, Geno DM, Johnson ML, Vela MF, Ravi K, Iyer PG, Katzka DA.

Neurogastroenterol Motil. 2018 Oct;30(10):e13403. doi: 10.1111/nmo.13403. Epub 2018 Jul 30.

PMID:
30062771
32.

Higher Rate of Barrett's Detection in the First Year After Successful Endoscopic Therapy: Meta-analysis.

Sawas T, Iyer PG, Alsawas M, Cotton CC, Leggett CL, Murad MH, Wang KK, Shaheen NJ, Katzka DA.

Am J Gastroenterol. 2018 Jul;113(7):959-971. doi: 10.1038/s41395-018-0090-z. Epub 2018 Jun 14.

PMID:
29899439
33.

Highly Discriminant Methylated DNA Markers for the Non-endoscopic Detection of Barrett's Esophagus.

Iyer PG, Taylor WR, Johnson ML, Lansing RL, Maixner KA, Yab TC, Simonson JA, Devens ME, Slettedahl SW, Mahoney DW, Berger CK, Foote PH, Smyrk TC, Wang KK, Wolfsen HC, Ahlquist DA.

Am J Gastroenterol. 2018 Aug;113(8):1156-1166. doi: 10.1038/s41395-018-0107-7. Epub 2018 Jun 12.

PMID:
29891853
34.

Accuracy of Endoscopic Ultrasound Imaging in Distinguishing Celiac Ganglia From Celiac Lymph Nodes.

Malikowski T, Lehrke HD, Henry MR, Gleeson FC, Topazian MD, Harmsen WS, Takahashi N, Inoue D, Gara N, Abu Dayyeh BK, Chari ST, Iyer PG, Rajan E, Wang KK, Levy MJ.

Clin Gastroenterol Hepatol. 2019 Jan;17(1):148-155.e3. doi: 10.1016/j.cgh.2018.05.025. Epub 2018 May 29.

PMID:
29857152
35.

Point-Counterpoint: Screening and Surveillance for Barrett's Esophagus, Is It Worthwhile?

Otaki F, Iyer PG.

Dig Dis Sci. 2018 Aug;63(8):2081-2093. doi: 10.1007/s10620-018-5065-9. Review.

PMID:
29713986
36.

Screening for esophageal squamous cell carcinoma: recent advances.

Codipilly DC, Qin Y, Dawsey SM, Kisiel J, Topazian M, Ahlquist D, Iyer PG.

Gastrointest Endosc. 2018 Sep;88(3):413-426. doi: 10.1016/j.gie.2018.04.2352. Epub 2018 Apr 27. Review. No abstract available.

PMID:
29709526
37.

Barrett Esophagus Length, Nodularity, and Low-grade Dysplasia are Predictive of Progression to Esophageal Adenocarcinoma.

Solanky D, Krishnamoorthi R, Crews N, Johnson M, Wang K, Wolfsen H, Fleischer D, Ramirez FC, Katzka D, Buttar N, Iyer PG.

J Clin Gastroenterol. 2019 May/Jun;53(5):361-365. doi: 10.1097/MCG.0000000000001027.

PMID:
29608452
38.

Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.

Dong J, Levine DM, Buas MF, Zhang R, Onstad L, Fitzgerald RC; Stomach and Oesophageal Cancer Study (SOCS) Consortium, Corley DA, Shaheen NJ, Lagergren J, Hardie LJ, Reid BJ, Iyer PG, Risch HA, Caldas C, Caldas I, Pharoah PD, Liu G, Gammon MD, Chow WH, Bernstein L, Bird NC, Ye W, Wu AH, Anderson LA, MacGregor S, Whiteman DC, Vaughan TL, Thrift AP.

Clin Gastroenterol Hepatol. 2018 Oct;16(10):1598-1606.e4. doi: 10.1016/j.cgh.2018.03.007. Epub 2018 Mar 15.

39.

Association of sporadic and familial Barrett's esophagus with breast cancer.

Chan MQ, Blum AE, Chandar AK, Emmons AMLK, Shindo Y, Brock W, Falk GW, Canto MI, Wang JS, Iyer PG, Shaheen NJ, Grady WM, Abrams JA, Thota PN, Guda KK, Chak A.

Dis Esophagus. 2018 Apr 1;31(4). doi: 10.1093/dote/doy007.

40.

Cryotherapy for persistent Barrett's esophagus after radiofrequency ablation: a systematic review and meta-analysis.

Visrodia K, Zakko L, Singh S, Leggett CL, Iyer PG, Wang KK.

Gastrointest Endosc. 2018 Jun;87(6):1396-1404.e1. doi: 10.1016/j.gie.2018.02.021. Epub 2018 Feb 22. Review.

41.

The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis.

Codipilly DC, Chandar AK, Singh S, Wani S, Shaheen NJ, Inadomi JM, Chak A, Iyer PG.

Gastroenterology. 2018 Jun;154(8):2068-2086.e5. doi: 10.1053/j.gastro.2018.02.022. Epub 2018 Feb 16. Review.

42.

Comparative Assessment of Patient Preferences and Tolerability in Barrett Esophagus Screening: Results From a Randomized Trial.

Blevins CH, Egginton JS, Shah ND, Johnson ML, Iyer PG.

J Clin Gastroenterol. 2018 Nov/Dec;52(10):880-884. doi: 10.1097/MCG.0000000000000991.

43.

Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus.

Moinova HR, LaFramboise T, Lutterbaugh JD, Chandar AK, Dumot J, Faulx A, Brock W, De la Cruz Cabrera O, Guda K, Barnholtz-Sloan JS, Iyer PG, Canto MI, Wang JS, Shaheen NJ, Thota PN, Willis JE, Chak A, Markowitz SD.

Sci Transl Med. 2018 Jan 17;10(424). pii: eaao5848. doi: 10.1126/scitranslmed.aao5848.

44.

Recent Advances in Screening for Barrett's Esophagus.

Sami SS, Iyer PG.

Curr Treat Options Gastroenterol. 2018 Mar;16(1):1-14. doi: 10.1007/s11938-018-0166-2. Review.

45.

Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.

Dong J, Buas MF, Gharahkhani P, Kendall BJ, Onstad L, Zhao S, Anderson LA, Wu AH, Ye W, Bird NC, Bernstein L, Chow WH, Gammon MD, Liu G, Caldas C, Pharoah PD, Risch HA, Iyer PG, Reid BJ, Hardie LJ, Lagergren J, Shaheen NJ, Corley DA, Fitzgerald RC; Stomach and Oesophageal Cancer Study (SOCS) consortium, Whiteman DC, Vaughan TL, Thrift AP.

Gastroenterology. 2018 Apr;154(5):1273-1281.e3. doi: 10.1053/j.gastro.2017.12.003. Epub 2017 Dec 13.

46.

Factors Associated With Progression of Barrett's Esophagus: A Systematic Review and Meta-analysis.

Krishnamoorthi R, Singh S, Ragunathan K, Visrodia K, Wang KK, Katzka DA, Iyer PG.

Clin Gastroenterol Hepatol. 2018 Jul;16(7):1046-1055.e8. doi: 10.1016/j.cgh.2017.11.044. Epub 2017 Dec 2.

PMID:
29199147
47.

Genomic regions associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study.

Sun X, Chandar AK, Canto MI, Thota PN, Brock M, Shaheen NJ, Beer DG, Wang JS, Falk GW, Iyer PG, Abrams JA, Venkat-Ramani M, Veigl M, Miron A, Willis J, Patil DT, Nalbantoglu I, Guda K, Markowitz SD, Zhu X, Elston R, Chak A.

PLoS One. 2017 Oct 26;12(10):e0184962. doi: 10.1371/journal.pone.0184962. eCollection 2017.

48.

Incidence and predictors of osteoporotic fractures in patients with Barrett's oesophagus: a population-based nested case-control study.

Kumar S, Drake MT, Schleck CD, Johnson ML, Alexander JA, Katzka DA, Iyer PG.

Aliment Pharmacol Ther. 2017 Dec;46(11-12):1094-1102. doi: 10.1111/apt.14345. Epub 2017 Oct 5.

49.

Endoscopic submucosal dissection in endotherapy for Barrett's esophagus-related dysplasia and neoplasia: An essential or optional technique?

Iyer PG.

Gastrointest Endosc. 2017 Oct;86(4):623-625. doi: 10.1016/j.gie.2017.03.006. No abstract available.

PMID:
28917342
50.

Editorial: The Effect of Bias on Estimation of Improved Survival After Diagnosis of Barrett's Esophagus.

Zakko L, Visrodia K, Wang KK, Iyer PG.

Am J Gastroenterol. 2017 Aug;112(8):1265-1266. doi: 10.1038/ajg.2017.185.

Supplemental Content

Support Center